SHARE NOW
Join us for a pragmatic and insightful webinar addressing the pressing challenges confronting the cell and gene therapy biotech sector.
WATCH ON DEMAND | MEET THE PANEL
As this dynamic industry undergoes rapid transformation, staying ahead demands a proactive approach. In this webinar, we offer practical insights and advice to support biotechnology companies in confronting these challenges head-on, and championing success for cell and gene therapy biotech in 2024 and beyond.
WHAT TO EXPECT
A panel discussion featuring insights from industry leaders, focused on:
- The Investment Landscape: Explore the intricacies of securing investment in an increasingly competitive landscape. We’ll discuss strategies to attract and secure vital funding for innovation and growth.
- Operational Excellence and Quality: Learn how to refine your operations strategy while upholding the highest quality standards. Quality assurance and regulatory compliance are critical components of success for advanced therapies biotech.
- Market Access: Understand the hurdles involved in securing market access for your therapies. Gain insights into evolving regulations and best practices for achieving market approval.
- Pricing and Reimbursement: Navigate the complexities of pricing and reimbursement in the cell and gene therapy market. Learn strategies to ensure your therapies reach the patients who need them while maintaining profitability.
Our panel of experts will provide actionable insights and real-world examples to help you craft a proactive strategy for 2024. Whether you’re a seasoned biotech professional or new to the industry, you’ll gain valuable knowledge to drive your organization’s growth.
Part 2: The panel answers audience questions with an interactive Q&A.
WHO SHOULD ATTEND
- Biotech executives and leaders
- Researchers and scientists in cell and gene therapy
- Investors and venture capitalists
- Anyone interested in the future of biotech, and the cell and gene therapy industry
MEET THE PANEL
Peter Olagunji
Independent Board Director
March Biosciences
Tiziana Rossetti
Senior Associate
Sofinnova Partners
Nathalie Clement
Vice President, Vector Development, Translational Gene Therapies
Siren Biotechnology
Khandan Baradaran
Vice President
Ultragenyx
Hanna Lesch
CTO
Exothera
